Skip to main content
Clinical Trials/ITMCTR2000004011
ITMCTR2000004011Not yet recruitingPhase 1

Based on reducing airway hyperresponsiveness of children with asthma, observing the clinical effect of adding and subtracting Xingfu Liujunzi Decoction on chronic duration

Yueyang Hospital of Integraced Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • (1) It conforms to the diagnostic criteria of clinical chronic duration of asthma in western medicine.
  • (2) Between the ages of 5 and 14 years.
  • (3) Immunomodulatory drugs not used in Traditional Chinese and western medicine in the previous month were included.
  • (4) The legal guardian of the child agrees to participate in this study and signs the informed consent.

Exclusion Criteria

  • (1) Patients with heart, liver, kidney, hematopoietic system and other serious primary diseases and psychosis.
  • (2) Those with other lesions that, according to the judgment of the researchers, reduce the possibility of inclusion or complicate inclusion.
  • (3) Those who are participating in clinical trials of other drugs.

Investigators

Sponsor
Yueyang Hospital of Integraced Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Similar Trials